Metraipolis › archive › dc_4e8594cfd8f9

Maintenance Low-Dose BRAF Inhibition and Rituximab in Relapsed Hairy Cell Leukemia: A Therapeutic Alternative — Europe PMC PMID:41322834

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41322834
DOI
10.7759/cureus.95668
License (as archived)
solo-consultazione
Archived
2026-11-08T23:16:27.593Z
SHA-256 of the archived text
462eb56e1b9b544c194c7002447b304718cb96ef4d4c483b9e6e5c1c1e11728c
Stable URL of this page
https://metraipolis.com/documento/dc_4e8594cfd8f9

How to cite

Maintenance Low-Dose BRAF Inhibition and Rituximab in Relapsed Hairy Cell Leukemia: A Therapeutic Alternative — Europe PMC PMID:41322834 — Europe PMC (en), https://europepmc.org/article/MED/41322834 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4e8594cfd8f9 (Metraipolis archive dc_4e8594cfd8f9, sha256 462eb56e1b9b544c194c7002447b304718cb96ef4d4c483b9e6e5c1c1e11728c)
BibTeX
@misc{dc4e8594cfd8f9,
  title = {Maintenance Low-Dose BRAF Inhibition and Rituximab in Relapsed Hairy Cell Leukemia: A Therapeutic Alternative — Europe PMC PMID:41322834},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41322834},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4e8594cfd8f9; sha256 462eb56e1b9b544c194c7002447b304718cb96ef4d4c483b9e6e5c1c1e11728c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41322834. Agents can read the archived copy with the MCP tool read_document.